Cooper Ronald Harold Wilfred bought ENGN
January 30, 2026 · Form 4 insider transaction
Cooper Ronald Harold Wilfred bought 801,000 shares of enGene Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
801,000
Price
$0.00
Total value
N/A
InsiderCooper Ronald Harold Wilfred
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after801,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.